Radke, Katarzyna https://orcid.org/0000-0002-4460-0812
Aaltonen, Kristina
Muciño-Olmos, Erick A
Esfandyari, Javanshir
Adamska, Aleksandra
Siaw, Joachim T https://orcid.org/0000-0002-1286-4485
Adamic, Dora https://orcid.org/0009-0003-5487-5590
Lago, Chiara https://orcid.org/0000-0002-1317-7847
Mañas, Adriana
Seger, Alexandra
Hansson, Karin https://orcid.org/0000-0002-6993-7673
Rogova, Oksana https://orcid.org/0000-0002-5104-2943
Lehn, Sophie https://orcid.org/0000-0003-0219-8551
Mason, Daniel J
O’Donovan, Daniel J https://orcid.org/0009-0008-1901-4556
Roberts, Ian https://orcid.org/0009-0006-7736-762X
Lock, Antonia https://orcid.org/0000-0003-1179-5999
Brennan, Jane https://orcid.org/0000-0003-3222-5485
Pietras, Kristian https://orcid.org/0000-0001-6738-4705
Davies, Emma J https://orcid.org/0009-0007-7900-6913
Spégel, Peter
Bedoya-Reina, Oscar C
Brown, David
Thompson, Neil T
Spadoni, Cesare
Bexell, Daniel https://orcid.org/0000-0001-9426-9550
Funding for this research was provided by:
Agenzia Nazionale per le Nuove Tecnologie, l'Energia e lo Sviluppo Economico Sostenibile
aPODD Foundation
Healx Ltd.
Cancerfonden (20 0897 PjF)
Cancerfonden (23 2754 Pj)
Barncancerfonden (PR2020-0018)
Barncancerfonden (PR2023-0006)
Barncancerfonden (TJ2021-0137)
Barncancerfonden (PR2021-0129)
Barncancerfonden (TJ2021-0068)
Vetenskapsrådet (2021-02597)
Vetenskapsrådet (2023-02402)
Crafoordska Stiftelsen (20210593)
Region Skåne
Karolinska Institutet (2022-01925)
Kungliga Fysiografiska Sällskapet i Lund (41984)
Kungliga Fysiografiska Sällskapet i Lund (42964)
Article History
Received: 4 December 2024
Revised: 4 November 2025
Accepted: 14 November 2025
First Online: 23 December 2025
Disclosure and competing interests statement
: DBe has received research funding from Healx, ENEA, and aPODD Foundation for this project. CS is a shareholder of Oncoheroes Biosciences Inc. DM, DO, IR, AL, JB, ED, DBr, and NT are (or have been) employed at Healx. The remaining authors declare no competing interests.